The Big Move: ‘I don’t have the funds or the gusto’: My wife painted our house in Rustic Western — now Realtors want us to whitewash our lives away

‘The Big Move’ is a MarketWatch column looking at the ins and outs of real estate, from navigating the search for a new home to applying for a mortgage. Do you have a question about buying or selling a home? Do you want to know where your next move should be? Email Jacob Passy at TheBigMove@marketwatch.com. […]

Continue Reading

: ‘The more we talk about it, the more we’re validating the symptoms’: What we know about COVID vaccine side effects in women

Women have been more likely than men to report adverse reactions to COVID-19 vaccines — and public-health experts say preparing them for the range of possible side effects could help combat vaccine hesitancy. Women accounted for about 79% of adverse-event reports — most of them deemed “nonserious” — related to Pfizer PFE, +2.58% -BioNTech BNTX, +7.69% […]

Continue Reading

: ‘Racism is a public-health issue’: COVID-related restrictions impact some Americans more than others

Mobility restrictions imposed to stem COVID-19’s spread put many historically marginalized groups at higher risk for a range of negative “well-being” outcomes during the first stretch of the pandemic — lending support to the idea that “racism is a public-health issue,” said a study published this month in JAMA Network Open. Each 10% decrease in […]

Continue Reading

Earnings Outlook: Here’s how the ‘pause’ on J&J’s COVID-19 shot may or may not affect the company’s earnings

To what degree will Johnson & Johnson’s COVID-19 vaccine manufacturing issues and the federal “pause” over safety concerns weigh on investors’ mind when the company reports earnings next week? The answer is probably not much, at least this time around. Johnson & Johnson is expected to share its first-quarter earnings on Tuesday morning. This is […]

Continue Reading